Related references
Note: Only part of the references are listed.ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
Joachim Yahalom et al.
BLOOD (2020)
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
Steven P. Treon et al.
BLOOD (2020)
COVID-19 outcomes in patients with hematologic disease
Florent Malard et al.
BONE MARROW TRANSPLANTATION (2020)
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
Per Ljungman et al.
BONE MARROW TRANSPLANTATION (2020)
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy
Gordon Cook et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients
James A. Aries et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19
Santiago Thibaud et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies
Fernando Martin-Moro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis
Zeinab Mohseni Afshar et al.
JOURNAL OF INFECTION (2020)
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta et al.
CANCER DISCOVERY (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan
Heng Mei et al.
LANCET ONCOLOGY (2020)
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Jianbo Tian et al.
LANCET ONCOLOGY (2020)
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang et al.
LANCET ONCOLOGY (2020)
Reply to COVID-19 in persons with haematological cancers: a focus on myeloid neoplasms and risk factors for mortality
Bruno Fattizzo et al.
LEUKEMIA (2020)
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy
Andrea Ferrari et al.
PEDIATRIC BLOOD & CANCER (2020)
COVID-19 infection in children and adolescents with cancer in Madrid
Teresa de Rojas et al.
PEDIATRIC BLOOD & CANCER (2020)
COVID-19, impact on myeloma patients
Ines Dufour et al.
ANNALS OF HEMATOLOGY (2020)
Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis
Xiaomei Wu et al.
ANNALS OF MEDICINE (2020)
Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
Jose Maria Sanchez-Pina et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy
Stephen Booth et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
Antonio Cuneo et al.
BLOOD (2020)
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato et al.
BLOOD (2020)
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy
Thomas A. Fox et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Christian Karagiannidis et al.
LANCET RESPIRATORY MEDICINE (2020)
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti et al.
LANCET HAEMATOLOGY (2020)
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
David J. Pinato et al.
CANCERS (2020)
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
Beth Russell et al.
FRONTIERS IN ONCOLOGY (2020)
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Bo Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Does type of immunosupression influence the course of Covid-19 infection?
J. Razanamahery et al.
JOURNAL OF INFECTION (2020)
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K. Chu et al.
LANCET (2020)
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Lydia Scarfo et al.
LEUKEMIA (2020)
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands
Jaap van Doesum et al.
LEUKEMIA (2020)
Reply to CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report Analysis of six hematological centers in Lombardy On behalf of CLL commission of Lombardy Hematology Network (REL)
Gianluigi Reda et al.
LEUKEMIA (2020)
Impact of Covid-19 on the treatment of acute myeloid leukemia
Felicetto Ferrara et al.
LEUKEMIA (2020)
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth V. Robilotti et al.
NATURE MEDICINE (2020)
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic
Anna Faura et al.
PEDIATRIC BLOOD & CANCER (2020)
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Justin Jee et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies
Monika M. Biernat et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
COVID-19 Death Rates Are Higher in Rural Counties With Larger Shares of Blacks and Hispanics
Kent Jason G. Cheng et al.
JOURNAL OF RURAL HEALTH (2020)
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter
Ankur Varma et al.
LEUKEMIA (2020)
The Age-Related Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review, Meta-Analysis, and Meta-Regression
Karla Romero Starke et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Vassilis G. Giannakoulis et al.
JCO GLOBAL ONCOLOGY (2020)
Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis
Abhijeet Ashok Salunke et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis
Aakash Desai et al.
JCO GLOBAL ONCOLOGY (2020)
A new improved graphical and quantitative method for detecting bias in meta-analysis
Luis Furuya-Kanamori et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2018)
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
Zachary Munn et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Meta-analysis of prevalence
Jan J. Barendregt et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2013)
Share Paper
